These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 9834458)

  • 1. Identification of genes expressed in the rat prostate that are modulated differently by castration and Finasteride treatment.
    Avila DM; Fuqua SA; George FW; McPhaul MJ
    J Endocrinol; 1998 Dec; 159(3):403-11. PubMed ID: 9834458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of 5alpha-reductase in rat prostate reveals differential regulation of androgen-response gene expression by testosterone and dihydrotestosterone.
    Dadras SS; Cai X; Abasolo I; Wang Z
    Gene Expr; 2001; 9(4-5):183-94. PubMed ID: 11444528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Androgen metabolism in the prostate of the finasteride-treated, adult rat: a possible explanation for the differential action of testosterone and 5 alpha-dihydrotestosterone during development of the male urogenital tract.
    George FW
    Endocrinology; 1997 Mar; 138(3):871-7. PubMed ID: 9048585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential effect of 5 alpha-reductase inhibition and castration on androgen-regulated gene expression in rat prostate.
    Rittmaster RS; Magor KE; Manning AP; Norman RW; Lazier CB
    Mol Endocrinol; 1991 Jul; 5(7):1023-9. PubMed ID: 1719382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Androgen-induced prostate-specific antigen gene expression is mediated via dihydrotestosterone in LNCaP cells.
    Zhu YS; Cai LQ; You X; Cordero JJ; Huang Y; Imperato-McGinley J
    J Androl; 2003; 24(5):681-7. PubMed ID: 12954658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostate cancer cells differ in testosterone accumulation, dihydrotestosterone conversion, and androgen receptor signaling response to steroid 5α-reductase inhibitors.
    Wu Y; Godoy A; Azzouni F; Wilton JH; Ip C; Mohler JL
    Prostate; 2013 Sep; 73(13):1470-82. PubMed ID: 23813697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Androgen-induced regrowth in the castrated rat ventral prostate: role of 5alpha-reductase.
    Wright AS; Douglas RC; Thomas LN; Lazier CB; Rittmaster RS
    Endocrinology; 1999 Oct; 140(10):4509-15. PubMed ID: 10499505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of 5alpha-reductase enhances testosterone-induced expression of U19/Eaf2 tumor suppressor during the regrowth of LNCaP xenograft tumor in nude mice.
    Gupta S; Wang Y; Ramos-Garcia R; Shevrin D; Nelson JB; Wang Z
    Prostate; 2010 Oct; 70(14):1575-85. PubMed ID: 20564326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relative potency of testosterone and dihydrotestosterone in preventing atrophy and apoptosis in the prostate of the castrated rat.
    Wright AS; Thomas LN; Douglas RC; Lazier CB; Rittmaster RS
    J Clin Invest; 1996 Dec; 98(11):2558-63. PubMed ID: 8958218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Androgens are not major down-regulators of androgen receptor levels during growth of the immature rat penis .
    Shen R; Lin MC; Sadeghi F; Swerdloff RS; Rajfer J; Gonzalez-Cadavid NF
    J Steroid Biochem Mol Biol; 1996 Mar; 57(5-6):301-13. PubMed ID: 8639466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of competitive and noncompetitive 5α-reductase inhibitors on serum and intra-prostatic androgens in beagle dogs.
    Zhao XF; Yang Y; Wang W; Qiu Z; Zhang P; Wang B
    Chin Med J (Engl); 2013 Feb; 126(4):711-5. PubMed ID: 23422194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostatic involution in rats induced by a novel 5 alpha-reductase inhibitor, SK&F 105657: role for testosterone in the androgenic response.
    Lamb JC; English H; Levandoski PL; Rhodes GR; Johnson RK; Isaacs JT
    Endocrinology; 1992 Feb; 130(2):685-94. PubMed ID: 1733716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dihydrotestosterone and the concept of 5alpha-reductase inhibition in human benign prostatic hyperplasia.
    Bartsch G; Rittmaster RS; Klocker H
    Eur Urol; 2000 Apr; 37(4):367-80. PubMed ID: 10765065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacologic basis for the enhanced efficacy of dutasteride against prostatic cancers.
    Xu Y; Dalrymple SL; Becker RE; Denmeade SR; Isaacs JT
    Clin Cancer Res; 2006 Jul; 12(13):4072-9. PubMed ID: 16818707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PNU 157706, a novel dual type I and II 5alpha-reductase inhibitor.
    di Salle E; Giudici D; Radice A; Zaccheo T; Ornati G; Nesi M; Panzeri A; Délos S; Martin PM
    J Steroid Biochem Mol Biol; 1998 Feb; 64(3-4):179-86. PubMed ID: 9605412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CGP 53153: a new potent inhibitor of 5alpha-reductase.
    Häusler A; Allegrini PR; Biollaz M; Batzl C; Scheidegger E; Bhatnagar AS
    J Steroid Biochem Mol Biol; 1996 Feb; 57(3-4):187-95. PubMed ID: 8645628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Castration-like effects on the human prostate of a 5 alpha-reductase inhibitor, finasteride.
    Geller J; Sionit L
    J Cell Biochem Suppl; 1992; 16H():109-12. PubMed ID: 1283893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of finasteride, a 5 alpha-reductase inhibitor on prostate tissue androgens and prostate-specific antigen.
    Geller J
    J Clin Endocrinol Metab; 1990 Dec; 71(6):1552-5. PubMed ID: 1699965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Postnatal Offspring of Finasteride-Treated Male Rats Shows Hyperglycaemia, Elevated Hepatic Glycogen Storage and Altered GLUT2, IR, and AR Expression in the Liver.
    Kur P; Kolasa-Wołosiuk A; Grabowska M; Kram A; Tarnowski M; Baranowska-Bosiacka I; Rzeszotek S; Piasecka M; Wiszniewska B
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33513940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New steroidal 17β-carboxy derivatives present anti-5α-reductase activity and anti-proliferative effects in a human androgen-responsive prostate cancer cell line.
    Amaral C; Varela C; Correia-da-Silva G; Tavares da Silva E; Carvalho RA; Costa SC; Cunha SC; Fernandes JO; Teixeira N; Roleira FM
    Biochimie; 2013 Nov; 95(11):2097-106. PubMed ID: 23933094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.